OraSure (OSUR +5.3%) pops on news yesterday that the company has launched its OraQuick In-Home...


OraSure (OSUR +5.3%) pops on news yesterday that the company has launched its OraQuick In-Home HIV test at U.S. retailers nationwide and online. The roll-out marks the first infectious disease test ever to be made available directly to consumers for in-home use. In tandem with the launch, the company is also collaborating with a high profile celebrity as part of an ongoing HIV awareness campaign. Details will be shared via a national media webcast at 3 PM EST today.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs